Buprenorphine Coverage in the Medicare Part D Program for 2007 to 2018

Daniel M. Hartung, Kirbee Johnston, Jonah Geddes, Gillian Leichtling, Kelsey C. Priest, P. Todd Korthuis

Open source

DOI
10.1001/jama.2018.20391
Published
2019-02-12
Container
JAMA
Publisher
American Medical Association (AMA)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jama.2018.20391,
  title = {Buprenorphine Coverage in the Medicare Part D Program for 2007 to 2018},
  author = {Daniel M. Hartung and Kirbee Johnston and Jonah Geddes and Gillian Leichtling and Kelsey C. Priest and P. Todd Korthuis},
  year = {2019},
  journal = {JAMA},
  doi = {10.1001/jama.2018.20391},
  url = {https://doi.org/10.1001/jama.2018.20391}
}

RIS

TY  - JOUR
TI  - Buprenorphine Coverage in the Medicare Part D Program for 2007 to 2018
AU  - Daniel M. Hartung
AU  - Kirbee Johnston
AU  - Jonah Geddes
AU  - Gillian Leichtling
AU  - Kelsey C. Priest
AU  - P. Todd Korthuis
PY  - 2019
JO  - JAMA
DO  - 10.1001/jama.2018.20391
UR  - https://doi.org/10.1001/jama.2018.20391
ER  - 

APA

Hartung, D. M., Johnston, K., Geddes, J., Leichtling, G., Priest, K. C., & Korthuis, P. T. (2019). Buprenorphine Coverage in the Medicare Part D Program for 2007 to 2018. JAMA. https://doi.org/10.1001/jama.2018.20391

Source records